Literature DB >> 23683713

The adoption of chronic fatigue syndrome/myalgic encephalomyelitis case definitions to assess prevalence: a systematic review.

Samantha Johnston1, Ekua W Brenu, Donald R Staines, Sonya Marshall-Gradisnik.   

Abstract

PURPOSE: Prevalence estimates have been based on several case definitions of chronic fatigue syndrome (CFS). The purpose of this work is to provide a rigorous overview of their application in prevalence research.
METHODS: A systematic review of primary studies reporting the prevalence of CFS since 1990 was conducted. Studies were summarized according to study design, prevalence estimates, and case definition used to ascertain cases.
RESULTS: Thirty-one studies were retrieved, and eight different case definitions were found. Early estimates of CFS prevalence were based on the 1988 Centers for Disease Control and Prevention, Australian, and Oxford. The 1994 Centers for Disease Control and Prevention, however, has been adopted internationally, as a general standard. Only one study has reported prevalence according to the more recent, Canadian Consensus Criteria. Additional estimates were also found according to definitions by Ho-Yen, the 2005 Centers for Disease Control and Prevention empirical definition, and an epidemiological case definition.
CONCLUSIONS: Advances in clinical case definitions during the past 10 years such as the Canadian Consensus Criteria have received little attention in prevalence research. Future assessments of prevalence should consider adopting more recent developments, such as the newly available International Consensus Criteria. This move could improve the surveillance of more specific cases found within CFS.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23683713     DOI: 10.1016/j.annepidem.2013.04.003

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  18 in total

1.  Activity Pacing Self-Management in Chronic Fatigue Syndrome: A Randomized Controlled Trial.

Authors:  Daphne Kos; Inge van Eupen; Jill Meirte; Deborah Van Cauwenbergh; Greta Moorkens; Mira Meeus; Jo Nijs
Journal:  Am J Occup Ther       Date:  2015 Sep-Oct

2.  Chronic Fatigue Syndrome and Myalgic Encephalomyelitis: Toward An Empirical Case Definition.

Authors:  Leonard A Jason; Bobby Kot; Madison Sunnquist; Abigail Brown; Meredyth Evans; Rachel Jantke; Yolonda Williams; Jacob Furst; Suzanne D Vernon
Journal:  Health Psychol Behav Med       Date:  2015

3.  Autonomic Nervous System Functioning Related to Nocturnal Sleep in Patients With Chronic Fatigue Syndrome Compared to Tired Controls.

Authors:  Maija Orjatsalo; Anniina Alakuijala; Markku Partinen
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

4.  Defining Essential Features of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.

Authors:  Leonard A Jason; Madison Sunnquist; Abigail Brown; Jordan Reed
Journal:  J Hum Behav Soc Environ       Date:  2015-05-06

5.  Chronic fatigue syndrome (CFS)/Myalgic Encephalomyelitis (ME) and Fibromyalgia (FM): the foundation of a relationship.

Authors:  Pamela G Mckay; Colin R Martin; Helen Walker; Mick Fleming
Journal:  Br J Pain       Date:  2019-10-05

6.  Multivitamin mineral supplementation in patients with chronic fatigue syndrome.

Authors:  Daniela Maric; Snezana Brkic; Slavica Tomic; Aleksandra Novakov Mikic; Tatjana Cebovic; Vesna Turkulov
Journal:  Med Sci Monit       Date:  2014-01-14

Review 7.  Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.

Authors:  Kjetil Gundro Brurberg; Marita Sporstøl Fønhus; Lillebeth Larun; Signe Flottorp; Kirsti Malterud
Journal:  BMJ Open       Date:  2014-02-07       Impact factor: 2.692

8.  A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Samantha C Johnston; Ekua W Brenu; Sharni L Hardcastle; Teilah K Huth; Donald R Staines; Sonya M Marshall-Gradisnik
Journal:  Health Qual Life Outcomes       Date:  2014-04-30       Impact factor: 3.186

Review 9.  Myalgic Encephalomyelitis: Symptoms and Biomarkers.

Authors:  Leonard A Jason; Marcie L Zinn; Mark A Zinn
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

10.  A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life.

Authors:  Breanna Weigel; Natalie Eaton-Fitch; Rachel Passmore; Hélène Cabanas; Donald Staines; Sonya Marshall-Gradisnik
Journal:  Food Nutr Res       Date:  2021-06-07       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.